Professor Juan Marchal Believes Propanc Biopharmas Proenzyme Therapy May Offer New Treatment Opportunity for Cancer Patients financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
15.02.2021 - Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the Company’s Scientific Advisory .